DMRA
Damora Therapeutics, Inc.
20.20$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -3,739.2% | – | – | |
| – | -37.6% | -57.2% | -21.4% | -22.1% | -190.0% | – | +12.5% | +11.1% | -30.0% | +871.4% | -83.8% | – | |
| – | – | – | – | – | -54.8% | -41.9% | -3.9% | -4.7% | +194.5% | +548.9% | +96.0% | – | |
| – | – | – | – | -427.6% | – | – | – | -67.4% | +5,062.0% | -76.8% | -20.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.6% | -41.0% | +6.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +10.9% | -90.0% | – | |
| – | -1,422.1% | – | – | -306.2% | – | – | – | – | – | +10.1% | -97.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -3,739.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.